JOHANNESBURG, SOUTH AFRICA--(Marketwire - Oct 24, 2011) - [ www.stockcall.com/ ] offers investors comprehensive research on the Drug Manufacturers - Major industry and has completed analytical research on GlaxoSmithKline plc (NYSE: [ GSK ]) and Merck & Co. Inc. (NYSE: [ MRK ]). Register with us today at [ www.stockcall.com/ ] to have free access to these researches.

Large-cap pharmaceutical companies have performed steadily in recent months despite market volatility. Both GlaxoSmithKline plc and Merck and Co. Inc. have held their value well since the markets began to really shift at the beginning of August. While this is certainly encouraging, these major pharmaceutical companies will likely need to maintain their drug pipelines to continue on this course. Investors looking for free research on Merck & Co. Inc. are welcome to sign up at [ www.stockcall.com/MRK241011.pdf ].

[ www.stockcall.com/ ] is an online platform where investors doing their due-diligence on the Drug Manufacturers - Major industry can have easy and free access to our analyst research and opinions on GlaxoSmithKline plc and Merck & Co. Inc.; all investors need to do is register for a complimentary membership at [ https://stockcall.com/development/stockcall/page.php?name=register.html ].

Expiring exclusivity rights on several major drugs are a significant concern to several companies at this time. As a result, acquisition and buyout rumors have begun surfacing at increased rates. Investors in the industry would be wise to track all of the latest merger and acquisition activities. Register now at [ https://stockcall.com/development/stockcall/page.php?name=register.html ] to have free access to our reports on the Drug Manufacturers - Major industry.

Avoiding production delays will also be pivotal. The Food and Drug Administration recently issued a warning letter to GlaxoSmithKline alleging manufacturing violations at its UK-based plant. The letter warned that until all corrections have been completed, the FDA may withhold approval of new applications. Investors looking for free research on GlaxoSmithKline plc are welcome to sign up at [ www.stockcall.com/GSK241011.pdf ].

Visit [ www.stockcall.com/ ] to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.